A prospective study was carried out on 48 patients with HTLV I associated myelopathyltropical spastic paraparesis (HAMJTSP) to assess the association between this entity and Sjogren's syndrome. Fourteen patients (2901%) had chronic dacryosialadenitis confirmed by a positive Schirmer's test and salivary gland biopsy. None of these patients had evidence of collagen disease and tests for Ro, La, and rheumatoid factor were negative except in one case. Therefore, the dacryosialadenitis could not be classified as either primary or secondary Sjogren's syndrome. Ten of the 14 patients (71.4%) had other systems (haematological, articular, dermatological, or respiratory) involved apart from the neurological and exocrine gland pathology. The findings suggest that the dacryosialadenitis associated with HTLV I is a disease of viral origin distinct from Sjogren's syndrome. (J Neurol Neurosurg Psychiatry 1995;58:244-246) 
Myelopathy/tropical spastic paraparesis (HAMJTSP) associated with HTIV I is a clearly defined entity. The association of HAM/TSP with leukaemia/lymphoma, polyneuropathy, myositis, arthritis, lymphoalveolitis, and uveitis has been reported. Sjogren's syndrome is another association that has been reported in a few cases1 2 but there is no detailed description of this clinical picture in HAM/TSP. This is a prospective study attempting to define the frequency and clinical features of Sj6gren's syndrome in a large population of patients positive for HTLV I.
Patients and methods Forty eight patients with HAM/TSP were evaluated during 1993 in our department of neurology. The characteristics of the spastic paraparesis has been described elsewhere. [3] [4] [5] All patients were submitted to CSF examination, EMG, and nerve conduction studies, trimodal evoked potentials, and myelography; in some cases, CT and MRI were performed to exclude other causes of the paraparesis. Tests for venereal disease and HIV were negative in all cases. Status for HTLV I was determined either by enzyme linked immunosorbent assay (ELISA) or particle agglutination (Serodia Fujirebio) and confirmed by indirect immunofluorescence with the antigen of MT-2 cells and by western blot. Eight patients were studied with the polymerase chain reaction (Primers SK110, SKlll, SK112, SK188).
Xerophthalmia was detected by Schirmer's test in all patients. Absorption of less than 8 mm in both eyes was considered to be positive. The 14 positive patients were submitted to a biopsy of the minor salivary glands. After injecting local anaesthetic, three or more salivary glands were taken from the external border of the lower lip, dissected out, and fixed in neutral formol and/or Bouin's fluid. The histological study was carried out with haematoxylin and eosin and Gomori stain and the histochemical study for lymphocytes was performed with Dako quick staining mouse antihuman T cells.
A full blood count was performed in all patients to identify abnormal lymphocytes. Also, lymphocytes from blood and CSF were typed. In the blood samples they were separated from heparinised blood on a Ficollhypaque gradient and from the CSF by direct centrifugation. Cell identification was carried out by indirect immunofluorescence with monoclonal antibodies CD3, CD4, CD8 and CD22. Receptors for IL-2 in T lymphocytes in blood and CSF were studied in eight patients.
Serum protein electrophoresis with a Trisbarbitone sodium buffer at pH and radial immunodiffusion to measure the serum immunoglobulin concentration were performed in Merck agar. The IgG index was calculated in CSF and blood. Rheumatoid factor was measured by the latex method; extractable nuclear antibodies (Ro and La) by a double diffusion technique with purified cow thymus, and human spleen antigens and antinuclear antibodies with rat's kidneys.
Chronic dacryosialadenitis in HTLVI associated myleopathy Skin biopsies measuring 2 cm x 0 5 cm were taken from patients with skin lesions, fixed in formol or Bouin's fluid, processed in paraffin and stained with haematoxylin and eosin and Gomori stain. Other studies included bronchial brushing performed in two cases and bronchial biopsy in one.
Results
Fourteen out of 48 patients (29-1%) proved positive for Schirmer's test. This group was composed of 11 women and three men with an average age of 50 9 (range 32-71) years. All patients presented with a spastic paraparesis, generalised hyper-reflexia, usually including a jaw jerk; bilateral Babinski sign; neurogenic bladder in 78-2%. Two out of 14 had superficial and deep sensory changes that were minor.
Four patients had had paraparesis for 10 to 15 years; four for between five and nine years, and six for less than five years. Of these 14 patients, seven could walk unaided, three needed help, two used wheelchairs, and two were bedridden. Three cases developed a paraplegia in flexion.
All patients had bilateral xerophthalmia defined by Schirmer's test. Only half of the patients had dryness or red eyes, including one case with xerophthalmia and mouth ulcers. These symptoms began after the onset of the spastic paraparesis. The biopsies of the small salivary glands showed pronounced lymphocytic infiltrations even in those patients who did not complain of any symptoms. On the Chisholm and Mason scale,6 five cases were defined as grade 4, with more than one cluster of 50 or more lymphocytes per 4 mm2. Eight cases were defined as grade 3 with one lymphocytic cluster per 4 mm2 and two cases as grade 2, with diffuse lymphocytic infiltration (figure). The lymphocyte infiltrates contained plasma cells. Also, there was some loss or disruption of the acini and ductal proliferation. Twelve patients showed a multifocal sialadenitis. 
